About Westley Dupray
Westley Dupray is a director at PreciseDx.
Form D filings also name Westley Dupray as a director at Beta Bionics.
Westley Dupray first appears on SEC filings in 2023.
Experience
This experience comes from Westley Dupray's profile and from SEC filings. For roles taken from filings, the years are when the filings name Westley Dupray in the role, so the role may have started earlier or lasted longer.
LC
Leo Cancer Care Current
Board Observer
2026 – Present
PreciseDx, Inc. Current
Director
2024 – Present · New York, NY
Breast cancer recurrence risk assessments for clinical care teams.
EM
Eventide Asset Management Current
Partner, Senior Research Analyst
2021 – Present
LP
Leerink Partners
Vice President, Equity Research , Life Science Tools and Diagnostics
2018 – 2021
PH
Philips
Sr. Credit Risk Analyst (2016 – 2018)
Business Analyst Intern (2015)
2015 – 2018
UB
UBS
Wealth Management Intern
2016
Key Colleagues at Startups
The people Westley Dupray works with at each company, as listed on that company's latest Form D.
PreciseDx, Inc. · Form D, Oct 7, 2026
Eric Converse
Chief Executive Officer and director
Molly Harper
Director
Paul Roma
Chairman
EL
Erik Lium
Director
MJ
Michael Hennessy Jr.
Director
ES
Edward Sitar
Chief Financial Officer
Beta Bionics, Inc · Form D, Sep 15, 2023
SC
Sean Carney
Director
SF
Stephen Feider
Chief Financial Officer, Secretary
LK
Lennox Ketner
Director
FD
Francesco Draetta
Director
AB
Amanda Black
Director
ED
Edward Damiano
Executive Chairman
SS
Sean Saint
Chief Executive Officer and director
GG
Gilad Glick
Director
PC
Parker Cassidy
Director